000 | 01070 a2200313 4500 | ||
---|---|---|---|
005 | 20250514193603.0 | ||
264 | 0 | _c20040728 | |
008 | 200407s 0 0 eng d | ||
022 | _a0947-6075 | ||
024 | 7 |
_a10.1007/978-3-662-07310-0_5 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHalldin, C | |
245 | 0 | 0 |
_aPET for drug development. _h[electronic resource] |
260 |
_bErnst Schering Research Foundation workshop _c2004 |
||
300 |
_a95-109 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aBrain _xdiagnostic imaging |
650 | 0 | 4 | _aClinical Trials as Topic |
650 | 0 | 4 | _aDrug Design |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 |
_aRadiopharmaceuticals _xadverse effects |
650 | 0 | 4 | _aTomography, Emission-Computed |
650 | 0 | 4 | _aTomography, Emission-Computed, Single-Photon |
700 | 1 | _aGulyás, B | |
700 | 1 | _aFarde, L | |
773 | 0 |
_tErnst Schering Research Foundation workshop _gno. 48 _gp. 95-109 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/978-3-662-07310-0_5 _zAvailable from publisher's website |
999 |
_c14951590 _d14951590 |